Glowise editorial guide

GLP-1 Injection Leakage: Check the Device Before Deciding What Happened

Medication leaked during or after your GLP-1 shot? Check your exact device’s completion signs, record what is uncertain, and get advice before taking extra medicine.

Portrait of Maya Lee, Glowise Senior GLP-1 Content Editor

Maya Lee

Glowise Senior GLP-1 Content Editor

Published November 13, 20266 min read
Download the Glowise App

Share this guide

Xfin
Adult checking an instruction leaflet beside a medication carton and a notebook at a kitchen table.

If medication leaked during or after your GLP-1 injection, do not calculate a replacement dose from the wet patch or give yourself an extra shot to make up for it. First identify the exact device, check its own completion signs, and describe what happened to your pharmacist or prescriber if delivery remains uncertain.

A bead at the needle tip and medicine running down the skin are different observations. Neither the appearance of your skin nor a photograph can measure how much medication entered your body. A device’s completion signal helps explain how the device operated; substantial leakage still needs its own assessment.

Start with three details, before changing anything

Find the carton or dispensing label and note:

  1. Product and presentation: for example, Wegovy single-dose pen, Wegovy FlexTouch, Ozempic dial-a-dose pen, Mounjaro or Zepbound single-dose pen, KwikPen, or a syringe used with a vial. The brand name alone is not enough.
  2. What you saw: a bead at the needle tip, one small spot, a stream, a spray, or liquid spreading across the skin. Note whether it appeared before, during, or after removal.
  3. What the device did: the counter reading, yellow-bar movement, visible plunger, clicks, and whether you removed it before the instructed hold was finished. Write “did not see” if you did not check.

These are details for troubleshooting, not a formula for estimating missing milligrams. If you already put the device in a sharps container, do not retrieve it to complete the note.

Does a small drop mean the injection failed?

Not necessarily. The Ozempic pen Instructions for Use describe a drop remaining at the needle tip after injection as normal and say it does not affect the dose. The Mounjaro single-dose pen instructions also describe a drop of liquid or blood on the skin afterward as normal; press with cotton or gauze without rubbing.

Those specific statements do not establish that a stream or pool of liquid is normal. There is no drop-size chart in these instructions that converts a visible spill into a dose to replace. If you saw more than the small drop described, lifted the device early, or missed the expected completion cue, report those facts rather than deciding the dose was “mostly” delivered.

Match the completion check to your device

The checks below summarize current US manufacturer instructions. Use the leaflet supplied with your own presentation; these are retrospective checks after a problem, not a complete injection tutorial.

Wegovy single-dose pen, including Wegovy HD

The Wegovy IFU says to keep firm pressure against the skin until the yellow bar stops moving. The second click means injection is still ongoing. If the bar initially does not move, the instruction is to press more firmly. If it does not start or stops during injection, contact your healthcare provider or Novo Nordisk at 1-833-934-6891.

After removal, the needle cover locks: this pen cannot be stopped and restarted later. Report early removal or medicine on the skin. Its troubleshooting advice about maintaining pressure applies to the next injection; it does not tell you to replace a leaked dose now.

Ozempic dial-a-dose pen

For this Ozempic pen, 0 must line up with the dose pointer. The button then stays pressed and the needle stays in the skin while you count slowly to six. Removing it earlier can produce a stream from the needle; the IFU says the full dose will not be delivered in that situation.

Tell your pharmacist whether the counter reached 0 and whether you completed that hold. A leak alone does not establish a blocked needle or justify using the blocked-needle procedure. For device questions, Novo Nordisk’s listed contact is 1-888-693-6742.

Wegovy FlexTouch

This Wegovy presentation uses a counter, not the automatic pen’s yellow bar. Hold the dose button until 0 aligns with the pointer, then continue pressing with the needle in the skin while counting slowly to six. Tell your pharmacist if either part was interrupted; do not borrow the single-dose pen’s click rule.

Mounjaro or Zepbound single-dose pen

The Mounjaro and Zepbound single-dose pen instructions say to press and hold the injection button for up to ten seconds. The first click starts injection; the second signals completion. Check for the visible gray plunger.

If the gray plunger is not visible, contact Lilly at 1-800-545-5979 for further instructions. Until then, the IFUs say to store the pen safely to avoid an accidental needle stick. Do not dismantle it to inspect the needle or attempt another injection from that pen.

Mounjaro or Zepbound KwikPen

The US Mounjaro KwikPen and Zepbound KwikPen instructions use a different sequence: push the dose knob until it stops, hold it while counting slowly to five, and check for 0 in the dose window before removing the needle.

Their unfinished-injection instruction is specific: if 0 is absent after removal, insert the needle back into the skin and finish the injection without redialing. If you still do not think you received the full dose, do not start over or repeat the injection; contact your healthcare provider or Lilly at 1-800-545-5979.

That instruction concerns finishing the existing injection. It is not permission to dial another dose to compensate for liquid that leaked. If you saw substantial leakage, cannot identify the device, or cannot tell whether this instruction fits what happened, get advice before manipulating it further.

A prefilled syringe or a syringe filled from a vial

There is no universal pen-click or counter check for a syringe. The Ozempic prefilled-syringe IFU describes completion as the plunger reaching the bottom with the syringe empty. By contrast, the Mounjaro vial and Zepbound vial instructions say to push the plunger to inject and keep the needle in the skin for at least five seconds.

Use the exact supplied syringe/vial instructions. These completion steps do not quantify a spill. For a compounded product, contact the dispensing pharmacy and prescriber with the vial label and syringe details; a branded pen’s troubleshooting sequence cannot establish what happened with your syringe.

Who to contact, and what to ask

Your pharmacist can help identify the presentation, locate the matching leaflet, and review the sequence you followed. Your prescriber should resolve what to do about uncertain delivery and the next scheduled dose. The manufacturer can troubleshoot a branded device; use the contact above or the number on its carton. A device complaint and a treatment decision may require more than one of those conversations.

A short message is enough to start:

“I used [product, presentation, prescribed dose] at [time]. I saw [plain description]. The completion cue was [what I observed, or unknown], and I [did/did not/am unsure whether I] completed the hold. I have not taken extra medication. What should I do about this injection, and when should I take my next dose?”

Keep the carton and its lot information available. Record “delivery uncertain” beside the prescribed dose, rather than entering a guessed smaller amount or marking a second injection as needed. Add the advice you receive, including who gave it and the agreed next-dose timing. A paper note or phone note works; the useful part is preserving the uncertainty accurately.

Before the next injection, ask for a demonstration of the exact device if any step was unclear. Our semaglutide injection guide covers routine preparation and technique. For a changing skin symptom, use the separate injection-site reaction guide or Ozempic bruising guide. A skin mark and a delivery problem can happen together, but one does not measure the other.

Portrait of Maya Lee, Glowise Senior GLP-1 Content Editor

About the author

Maya Lee

Glowise Senior GLP-1 Content Editor

Maya Lee is a Glowise Health Content Editor. Her guides turn product records, authoritative sources, and everyday organization questions into clear, practical GLP-1 information.

She helps readers ask better questions and keep the details relevant to a care conversation together.

See more Glowise on Google

Add Glowise as a preferred source to find our GLP-1 guides more easily in Google Search.

Glowise library

Bring your GLP-1 routine into one place.

Download the Glowise app to keep medication, meals, hydration, side effects, and progress together.